83 related articles for article (PubMed ID: 11343267)
1. Antidiabetic treatment for NASH?
Maher J
Hepatology; 2001 May; 33(5):1338-9. PubMed ID: 11343267
[No Abstract] [Full Text] [Related]
2. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets.
Kakuma T; Lee Y; Higa M; Wang Zw; Pan W; Shimomura I; Unger RH
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8536-41. PubMed ID: 10900012
[TBL] [Abstract][Full Text] [Related]
3. [Troglitazone: its pharmacology and mechanism of action].
Horikoshi H; Fujiwara T
Nihon Rinsho; 1997 Nov; 55 Suppl():125-30. PubMed ID: 9434455
[No Abstract] [Full Text] [Related]
4. Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB-1 suppression or by correcting essential fatty acid deficiency.
Alwayn IP; Javid PJ; Gura KM; Nosé V; Ollero M; Puder M
Hepatology; 2004 Apr; 39(4):1176-7; author reply 1177-8. PubMed ID: 15057926
[No Abstract] [Full Text] [Related]
5. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Caldwell SH; Hespenheide EE; Redick JA; Iezzoni JC; Battle EH; Sheppard BL
Am J Gastroenterol; 2001 Feb; 96(2):519-25. PubMed ID: 11232700
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).
Diraison F; Parton L; Ferré P; Foufelle F; Briscoe CP; Leclerc I; Rutter GA
Biochem J; 2004 Mar; 378(Pt 3):769-78. PubMed ID: 14690455
[TBL] [Abstract][Full Text] [Related]
7. Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway.
Guillet-Deniau I; Pichard AL; Koné A; Esnous C; Nieruchalski M; Girard J; Prip-Buus C
J Cell Sci; 2004 Apr; 117(Pt 10):1937-44. PubMed ID: 15039461
[TBL] [Abstract][Full Text] [Related]
8. Induction of stearoyl CoA desaturase is associated with high-level induction of emerin RNA.
Mziaut H; Korza G; Elkahloun AG; Ozols J
Biochem Biophys Res Commun; 2001 Apr; 282(4):910-5. PubMed ID: 11352637
[TBL] [Abstract][Full Text] [Related]
9. Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats.
Shimabukuro M; Zhou YT; Lee Y; Unger RH
Biochem Biophys Res Commun; 1997 Aug; 237(2):359-61. PubMed ID: 9268716
[TBL] [Abstract][Full Text] [Related]
10. Diabetes medicine update. Old dogs, new tricks.
Nakamoto M
Diabetes Self Manag; 2003; 20(1):14-5. PubMed ID: 12632553
[No Abstract] [Full Text] [Related]
11. [Are PPAR-gamma-agonists a secure choice in treatment of overweight diabetic patients?].
Larsen PJ
Ugeskr Laeger; 2000 Aug; 162(32):4280-1. PubMed ID: 10962950
[No Abstract] [Full Text] [Related]
12. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
Algenstaedt P; Hamann A
Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
[No Abstract] [Full Text] [Related]
13. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
14. Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats.
Nogalska A; Sucajtys-Szulc E; Swierczynski J
Metabolism; 2005 Aug; 54(8):1041-7. PubMed ID: 16092054
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and nonalcoholic steatohepatitis: fat or fiction?
Sanyal AJ
Am J Gastroenterol; 2001 Feb; 96(2):274-6. PubMed ID: 11232664
[No Abstract] [Full Text] [Related]
16. Pioglitazone trial for NASH: results show promise.
Lang L
Gastroenterology; 2007 Mar; 132(3):836-8. PubMed ID: 17383411
[No Abstract] [Full Text] [Related]
17. SREBPs suppress IRS-2-mediated insulin signalling in the liver.
Ide T; Shimano H; Yahagi N; Matsuzaka T; Nakakuki M; Yamamoto T; Nakagawa Y; Takahashi A; Suzuki H; Sone H; Toyoshima H; Fukamizu A; Yamada N
Nat Cell Biol; 2004 Apr; 6(4):351-7. PubMed ID: 15048126
[TBL] [Abstract][Full Text] [Related]
18. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
19. Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat.
Frick F; Lindén D; Améen C; Edén S; Mode A; Oscarsson J
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1023-31. PubMed ID: 12376331
[TBL] [Abstract][Full Text] [Related]
20. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
Kuscu NK; Koyuncu FM
Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
